Navigation Links
$1.6 million to take forward breakthrough research in heart disease

Clues to the causes of serious, and often fatal, diseases and conditions, such as heart disease, stroke and high blood pressure, are being investigated at the Universities of Strathclyde and Glasgow, both in Scotland, with the use of a 1 million grant.

Scientists at the universities have made a breakthrough in techniques for exploring faults in 'smooth' muscles, which play a major part in controlling blood flow, blood pressure and the digestion of food.

For all of this to operate properly, the muscles must act in a co-ordinated way but how they do so is still not fully understood. However, it is known that calcium plays a part and the researchers have developed an innovative system for looking at calcium in targeted areas of blood cells.

They have received a 1million programme grant from the Wellcome Trust to take their investigation further.

Professor John McCarron, of the Strathclyde Institute of Pharmacy and Biomedical Sciences said: "The malfunction of smooth muscle is a cause of many debilitating diseases and conditions and problems with controlling calcium are underlying in conditions like hypertension. We have to find out how and why it happens if we are to tackle these illnesses.

"Until now, research in this area had been complicated by the fact that cells which are grown in lab conditions for study very quickly cease to resemble or function like real cells, so the meaning of results from these cells is often unclear.

"We have now developed an innovative system of analysis which can be applied to real cells, in ways which were not previously possible. This research could help to shape the future of cardiovascular treatments."

Professor McCarron, and his co-investigator Dr Richard Hartley of the University of Glasgow, are using an advanced combination of biomedical microscopy and chemical biology. They have developed innovative procedures which can be targeted at specific parts of a cell, so that calcium changes in small areas can be studied, manipulated and understood.


Contact: Paul Gallagher
University of Strathclyde

Related biology news :

1. NIH awards $10 million to advance microneedle patch for flu vaccination
2. Aeras awarded €11.7 million ($16 million) grant from Dutch government
3. $2.7 million research award to aid nursery, floriculture industry
4. New statistical model moves human evolution back 3 million years
5. Helmsley Charitable Trust awards more than $15 million to Salk Institute-CUMC
6. USAID awards $5 million to CONRAD
7. $12 million grant to probe root causes of heart failure
8. MegaMatcher Accelerator 3.0 for Rapid Biometric Identification Matches Up to 200 Million Irises or 100 Million Fingerprints Per Second
9. NIH renews Nanomedicine Center focused on treating single-gene disorders for $16.1 million
10. European R&D leaders assembled in Tel Aviv will invest $70 million in joint R&D initiatives
11. USDA awards Virginia Tech $3.8 million to stimulate eastern US wine industry
Post Your Comments:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):
(Date:12/1/2015)...  CardioCell LLC, a Stemedica Cell Technologies Inc. ... indications, intends to proceed with finalizing a Phase ... a Heart Failure Advisory Board comprising cardiology key ... members . In a recent meeting members of ... efficacy data from CardioCell,s on-going chronic heart failure ...
(Date:12/1/2015)... Frederick, MD (PRWEB) , ... December 01, 2015 ... ... management solutions provider, announces that its best selling system laboratory animal colony management ... ezColony® Cloud today, without investing in on-site IT resources., , ...
(Date:12/1/2015)... SAN FRANCISCO , Dec. 1, 2015  Symic, ... and affect the extracellular matrix (ECM), today announced that ... financing to advance the company,s pipeline, including its lead ... Lilly Ventures and includes the participation by all existing ... new funding brings the total capital raised by Symic ...
(Date:12/1/2015)... , December 1, 2015 Dr. Harry Lander , President ... serving as Chief Science Officer and recruits five ... Harry Lander , President of Regen, expands his role to ... recruits five distinguished scientists to join advisory team ... expands his role to include serving as ...
Breaking Biology Technology: